1. HBW Insight
  2. >>Health
  3. >>Business
  4. >>Earnings

End Of Year Recovery Ensures Recordati’s OTC Business Keeps Growing

 
• By Tom Gallen

Jump in cough & cold sales at the end of the year helps Recordati post higher OTC revenues for 2024.

Holding_Arrow
• Source: Shutterstock

A strong end to the year for its cough and cold portfolio after a difficult first half helped Recordati Industria Chimica & Farmaceutica SPA to record a small rise in OTC sales in 2024.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Earnings

‘The Only Certainty Is Uncertainty’ In The UK’s Consumer Health Market

 
• By David Ridley

While uncertainty might reign in the UK consumer health market - which grew by by 8% to £4.1bn ($5.3bn) in 2024 - “opportunity is everywhere” according to NielsenIQ health and beauty insights manager Alex Heffernan.

France’s Boiron Looks To Future After Challenging Year

 
• By Tom Gallen

The homeopathy specialist reported a big decline in profits in 2024 as a move to restructure its ailing French operation hit the bottom line.

Reducing Complexity Helps Weleda Break Sales Record

 
• By Tom Gallen

Swiss firm reports highest revenues in its history as restructure pays off for its pharma and cosmetics businesses in 2024.

End Of Year Recovery Ensures Recordati’s OTC Business Keeps Growing

 
• By Tom Gallen

Jump in cough & cold sales at the end of the year helps Recordati post higher OTC revenues for 2024.

More from Strategy

End Of Year Recovery Ensures Recordati’s OTC Business Keeps Growing

 
• By Tom Gallen

Jump in cough & cold sales at the end of the year helps Recordati post higher OTC revenues for 2024.

Alfasigma Seeking Slice Of EU’s Largest OTC Market With German Launch

 
• By Tom Gallen

Italy's Alfasigma has expanded its operation in Germany with the creation of a new Consumer Healthcare unit. Led by Rüdiger Hoppe, the business is rolling out OTC medical devices and dietary supplements in the gastrointestinal category.

People On The Move: Appointments At PAGB, Activ’Inside, EMA

 
• By Tom Gallen

Round up of the latest appointments: PAGB names vice presidents; Activ'Inside gets first US head; EMA elects management board chair.